MeSH D003027 - cluster headache
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Sumatriptan | Sumatriptan |  | 2009-02-09 |  |  |
| Sumatriptan | Zecuity | 2023-02-21 | 2013-01-17 |  |  | |
| Padagis | Sumatriptan | Sumatriptan |  | 2020-09-21 |  |  |
| Mylan | Sumatriptan | Sumatriptan |  | 2009-11-02 |  |  |
| GSK | Sumatriptan | Imitrex |  | 1995-06-01 |  |  |
| Sumatriptan | Imitrex Statdose |  | 1992-12-28 |  |  | |
| Cipla | Sumatriptan | Sumatriptan |  | 2021-02-22 |  |  |
| Sandoz | Sumatriptan | Sumatriptan |  | 2009-02-06 |  |  |
| Novartis | Heparin, Lidocaine, Dihydroergotamine | Embolex |  | 1984-11-30 |  |  |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
58%7/12
Phase 2
35%6/17
Phase 3
52%14/27
Approved: 7Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use